Compare Global E Online Ltd (GLBE) vs Hims and Hers Health Inc (HIMS) Price & Performance

GLBE trades at $40.15, up 3.05% today, with strong technical momentum showing bullish moving averages and neutral oscillators. The company reported Q2 2026 earnings beat with revenue growth of 39% YoY and raised full-year guidance. Recent executive appointments and strong institutional interest support the positive outlook.

The stock offers significant upside to the $48.86 consensus price target, supported by robust revenue growth and expanding margins. Key risks include insider selling activity and elevated valuation multiples. Wall Street maintains strong bullish sentiment with 93% buy ratings.

HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.

The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.